BioCentury
ARTICLE | Clinical News

Alista alprostadil: VVUS will begin this quarter a U.S. Phase II/III trial evaluating Alista in the at-home setting.

January 28, 2002 8:00 AM UTC

Vivus Inc. (VVUS), Mountain View, Calif. Product: Alista alprostadil Business: Reproductive Therapeutic category: Vasodilation Target: Smooth muscle cells Description: Topical formulation of alprostad...